Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN ra... von Cortes, Jorge E., Jiang, Qian, Wang, Jianxiang, Weng, Jianyu, Zhu, Huanling, Liu, Xiaoli, Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald, Savona, Michael, Martin-Regueira, Patricia, Sy, Oumar, Gurnani, Renuka, Saglio, Giuseppe

Volltext

Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and... von Cortes, Javier, Vahdat, Linda, Blum, Joanne L, Twelves, Chris, Campone, Mario, Roché, Henri, Bachelot, Thomas, Awada, Ahmad, Paridaens, Robert, Goncalves, Anthony, Shuster, Dale E, Wanders, Jantien, Fang, Fang, Gurnani, Renuka, Richmond, Elaine, Cole, Patricia E, Ashworth, Simon, Allison, Mary Ann

Volltext

Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dasce... von Cortes, Jorge E., Jiang, Qian, Wang, Jianxiang, Weng, Jianyu, Zhu, Huanling, Xiaoli, Liu, Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald, Savona, Michael R., Martin Regueira, Patricia, Sy, Oumar, Gurnani, Renuka, Saglio, Giuseppe

Volltext